Pulmonary capillary pressure measurement from pulmonary artery occlusion pressure decay profile analysis in sheep. 1995

G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
Department of Anesthesia, Stanford University School of Medicine, CA 94305, USA.

Pulmonary capillary pressure (Ppc), the major factor responsible for pulmonary edema, cannot be directly measured in intact subjects but may be estimated by analysis of the pressure decay profile after pulmonary artery catheter balloon inflation. We compared three different methods of pulmonary artery occlusion pressure (Ppao) decay profile analysis to estimates of Ppc derived from lymph flow measurements in halothane-anesthesized sheep. The relationship between Ppc and lymph flow was first determined by increasing Ppc by left atrial balloon inflation, and was then used to determine Ppc during pulmonary hypertension produced by infusion of a thromboxane analog. All three methods of Ppao decay profile analysis demonstrated a correlation with Ppc estimated from lymph flow. However, the method using a single exponential analysis significantly overestimated Ppc, and none of the methods reliably estimated changes in the longitudinal distribution of pulmonary vascular resistance during pulmonary hypertension. These results suggest that Ppao decay profile analysis as currently performed has limited application.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008196 Lymph The interstitial fluid that is in the LYMPHATIC SYSTEM. Lymphs
D008297 Male Males
D011450 Prostaglandin Endoperoxides, Synthetic Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. Prostaglandin Endoperoxide Analogs,Prostaglandin Endoperoxide Analogues,Synthetic Prostaglandin Endoperoxides,Analogues, Prostaglandin Endoperoxide,Endoperoxide Analogues, Prostaglandin,Endoperoxides, Synthetic Prostaglandin
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011654 Pulmonary Edema Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening. Wet Lung,Edema, Pulmonary,Edemas, Pulmonary,Pulmonary Edemas,Lung, Wet,Lungs, Wet,Wet Lungs
D011669 Pulmonary Wedge Pressure The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES. Pulmonary Artery Wedge Pressure,Pulmonary Capillary Wedge Pressure,Pulmonary Venous Wedge Pressure,Wedge Pressure,Pressure, Pulmonary Wedge,Pressures, Pulmonary Wedge,Pulmonary Wedge Pressures,Wedge Pressure, Pulmonary,Wedge Pressures, Pulmonary,Pressure, Wedge,Pressures, Wedge,Wedge Pressures
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan

Related Publications

G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
January 1986, Critical care medicine,
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
January 1993, Anesthesia and analgesia,
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
December 1987, Journal of applied physiology (Bethesda, Md. : 1985),
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
August 1983, The American review of respiratory disease,
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
January 2003, Intensive care medicine,
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
February 1988, Anesthesiology,
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
October 1992, Journal of applied physiology (Bethesda, Md. : 1985),
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
November 1983, Chest,
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
November 1989, The American review of respiratory disease,
G E Wakerlin, and J C Finn, and L C Siegel, and G V Benson, and T F Flavin, and R G Pearl
June 1994, Critical care medicine,
Copied contents to your clipboard!